Jonah Comstock

BMJ: Symptom checkers get diagnosis right 34 percent of the time on average
By Jonah Comstock | 11:56 am | July 13, 2015
Sharecare's AskMD.
Why Pharma might be especially interested in ResearchKit
By Jonah Comstock | 11:22 am | July 13, 2015
When Apple first announced ResearchKit, it was met with a fair amount of skepticism about whether the data collected via smartphones would be robust enough to be useful.
Health 2.0: $2.2B in digital health funding so far this year
By Jonah Comstock | 10:32 am | July 09, 2015
In one more take on the first half of 2015 funding, Health 2.
Jawbone promises to pick up slack if ITC blocks Fitbit imports
By Jonah Comstock | 10:04 am | July 09, 2015
Jawbone's beef with competitor Fitbit is heating up, according to a report from Bloomberg.
PillPack launches medication reminder app for iPhone, Apple Watch
By Jonah Comstock | 05:00 am | July 09, 2015
PillPack, the mail-order pharmacy that raised $50 million last June, has finally gone mobile, launching its first app, for iOS and Apple Watch.
Dr. Google is more research scientist than practicing doc now
By Jonah Comstock | 12:29 pm | July 08, 2015
At the end of 2013 MobiHealthNews published a long post called "Checking up on Dr.
Roche launches FDA-cleared diabetes app with insulin calculator in US
By Jonah Comstock | 12:28 pm | July 08, 2015
Last month, Roche quietly launched its Accu-Chek Connect app, a diabetes management app which contains, among other things, an unprecented feature: a prescription insulin bolus calculator called Bolus Advisor.
NIH seeks feedback on how to collect clinical data via smartphones, wearables
By Jonah Comstock | 11:20 am | July 07, 2015
Fitbit Surge It looks like the NIH may be the next big stakeholder to look to mobile tools for data collection in clinical research, joining the likes of Apple and Google.
Rock Health: $2.1B in digital health funding so far this year
By Jonah Comstock | 07:14 am | July 07, 2015
The year so far has seen 136 digital health investment deals over $2 million, for a total of $2.
23andMe raises $79 million as it shifts focus to research, drug development
By Jonah Comstock | 10:34 am | July 06, 2015
According to an SEC filing, mail-order personal genome service and research company 23andMe has raised $79 million, in a round the company hopes will top out at $150 million.